Multicancer detection tests had sensitivity from 0.095 to 0.998, specificity from 0.657 to 1.0, and area under the receiver ...

Diabetes incidence was significantly higher among those in the cannabis cohort compared with the healthy cohort.

Women were significantly underrepresented in cardiovascular clinical trials compared with men in recent years.

Increased ASD prevalence among children with prenatal exposure to prescribed opioid analgesics was attenuated in sibling comparisons.

Upadacitinib and secukinumab for PsA offers comparable improvements in skin and joint symptoms, but adalimumab offers superior pain relief.

California, Hawaii, Oregon and Washington issued COVID-19, influenza, and RSV vaccination guidance in line with former CDC recommendations.

The FDA has approved updated labeling for Vyjuvek (beremagene geperpavec-svdt), a topical gene therapy for dystrophic epidermolysis bullosa.

The USDA will no longer publish Household Food Security reports, which inform food assistance programs in the US.

The FDA has expanded the approval of Opzelura to include patients 2 to 11 years of age for treatment of mild to moderate atopic dermatitis.

The ACIP voted to recommend that the combined MMRV vaccine not be given before age 4 years and will vote on the hepatitis B vaccine Friday.

The biosimilar BAT2206 is comparable to the reference product ustekinumab for the treatment of plaque psoriasis for up to 52 weeks.

ACIP voted unanimously to recommend that adults aged more than 65 years discuss with an HCP before receiving the COVID-19 vaccines.